Intravitreal dexamethasone implant versus anti-vascular endothelial growth factor therapy combined with cataract surgery in patients with diabetic macular oedema: a systematic review with meta-analysis.
Matteo FallicoAndrew John LoteryAndrea MaugeriGiuliana FavaraMartina BarchittaAntonella AgodiAndrea RussoAntonio LongoVincenza BonfiglioTeresio AvitabilePaola MaroloEnrico BorrelliGuglielmo ParisiGilda CennamoClaudio FurinoMichele ReibaldiPublished in: Eye (London, England) (2021)
In DMO patients, cataract surgery combined with DEX seems to provide better anatomical outcomes compared with cataract surgery combined with anti-VEGF therapy. However, our evidence was limited by significant heterogeneity. Randomised trials comparing these two different combined approaches are warranted.
Keyphrases
- cataract surgery
- vascular endothelial growth factor
- endothelial cells
- clinical trial
- ejection fraction
- end stage renal disease
- type diabetes
- low dose
- stem cells
- high dose
- insulin resistance
- skeletal muscle
- patient reported outcomes
- adipose tissue
- single cell
- cell therapy
- study protocol
- soft tissue
- optical coherence tomography